These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9123135)
1. Influence of allograft coronary artery disease on survival and cardiac function in the decade following orthotopic cardiac transplantation. Grocott-Mason RM; Bustami M; Banner N; O'Brien C; Khaghani A; Yacoub M; Mitchell AG Transplant Proc; 1997; 29(1-2):576-7. PubMed ID: 9123135 [No Abstract] [Full Text] [Related]
2. The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy. Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M Transplant Proc; 2007 Nov; 39(9):2866-9. PubMed ID: 18022004 [TBL] [Abstract][Full Text] [Related]
3. Cardiac allograft vasculopathy: pathology, prevention and treatment. Kass M; Haddad H Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150 [TBL] [Abstract][Full Text] [Related]
5. Natural history of allograft coronary arteriopathy: a retrospective study of 54 patients over a 8 1/2-year period. Park SJ; Pifarre R; Sullivan H; Montoya A; Kim SY Cardiovasc Surg; 1996 Feb; 4(1):37-41. PubMed ID: 8634844 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft. Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768 [TBL] [Abstract][Full Text] [Related]
7. Midterm results of percutaneous transluminal coronary angioplasty in graft coronary artery disease in cardiac transplant patients. Marelli M; Rábago G; Calabuig J; Martínez Caro D; Coma-Canella I; Martín Trenor A Transplant Proc; 1999 Sep; 31(6):2539-41. PubMed ID: 10500707 [No Abstract] [Full Text] [Related]
8. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation. Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643 [TBL] [Abstract][Full Text] [Related]
9. [Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings]. Kerber S; Rahmel A; Karbenn U; Heinemann-Vechtel O; Fechtrup C; Lamp B; Block M; Budde T; Hoffmeier A; Weyand M Z Kardiol; 1994 Mar; 83(3):215-24. PubMed ID: 8178545 [TBL] [Abstract][Full Text] [Related]
10. Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation. Potluri SP; Mehra MR; Uber PA; Park MH; Scott RL; Ventura HO J Heart Lung Transplant; 2005 Aug; 24(8):1019-25. PubMed ID: 16102436 [TBL] [Abstract][Full Text] [Related]
11. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease. Brunner-La Rocca HP; Schneider J; Künzli A; Turina M; Kiowski W Transplantation; 1998 Feb; 65(4):538-43. PubMed ID: 9500630 [TBL] [Abstract][Full Text] [Related]
12. Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy. Zuckermann A; Ploner M; Czerny M; Keziban U; Birsan T; Laufer G; Wolner E; Grimm M Transplant Proc; 2002 Aug; 34(5):1869-71. PubMed ID: 12176608 [No Abstract] [Full Text] [Related]
13. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation. Kübrich M; Petrakopoulou P; Kofler S; Nickel T; Kaczmarek I; Meiser BM; Reichart B; von Scheidt W; Weis M Transplantation; 2008 Jun; 85(11):1580-7. PubMed ID: 18551063 [TBL] [Abstract][Full Text] [Related]
14. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P; Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361 [TBL] [Abstract][Full Text] [Related]
15. The influence of donor age on transplant coronary artery disease and survival post heart transplantation: is it safe to extend donor age? Walker AH; Fildes JE; Leonard CT; Yonan N Transplant Proc; 2004 Dec; 36(10):3139-41. PubMed ID: 15686713 [TBL] [Abstract][Full Text] [Related]